HEADER    PROTEIN TRANSPORT/INHIBITOR             12-JUL-22   8DNZ              
TITLE     CRYO-EM STRUCTURE OF THE HUMAN SEC61 COMPLEX INHIBITED BY APRATOXIN F 
COMPND    MOL_ID: 1;                                                            
COMPND   2 MOLECULE: PROTEIN TRANSPORT PROTEIN SEC61 SUBUNIT GAMMA;             
COMPND   3 CHAIN: B;                                                            
COMPND   4 ENGINEERED: YES;                                                     
COMPND   5 MOL_ID: 2;                                                           
COMPND   6 MOLECULE: PROTEIN TRANSPORT PROTEIN SEC61 SUBUNIT BETA;              
COMPND   7 CHAIN: C;                                                            
COMPND   8 ENGINEERED: YES;                                                     
COMPND   9 MOL_ID: 3;                                                           
COMPND  10 MOLECULE: PROTEIN TRANSPORT PROTEIN SEC61 SUBUNIT ALPHA ISOFORM 1;   
COMPND  11 CHAIN: A;                                                            
COMPND  12 SYNONYM: SEC61 ALPHA-1;                                              
COMPND  13 ENGINEERED: YES;                                                     
COMPND  14 MUTATION: YES;                                                       
COMPND  15 MOL_ID: 4;                                                           
COMPND  16 MOLECULE: APRATOXIN F PEPTIDE INHIBITOR;                             
COMPND  17 CHAIN: D                                                             
SOURCE    MOL_ID: 1;                                                            
SOURCE   2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;                                   
SOURCE   3 ORGANISM_COMMON: HUMAN;                                              
SOURCE   4 ORGANISM_TAXID: 9606;                                                
SOURCE   5 GENE: SEC61G;                                                        
SOURCE   6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA;                            
SOURCE   7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM;                             
SOURCE   8 EXPRESSION_SYSTEM_TAXID: 7108;                                       
SOURCE   9 EXPRESSION_SYSTEM_CELL_LINE: SF9;                                    
SOURCE  10 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS;                          
SOURCE  11 EXPRESSION_SYSTEM_PLASMID: PFASTBAC;                                 
SOURCE  12 MOL_ID: 2;                                                           
SOURCE  13 ORGANISM_SCIENTIFIC: HOMO SAPIENS;                                   
SOURCE  14 ORGANISM_COMMON: HUMAN;                                              
SOURCE  15 ORGANISM_TAXID: 9606;                                                
SOURCE  16 GENE: SEC61B;                                                        
SOURCE  17 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA;                            
SOURCE  18 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM;                             
SOURCE  19 EXPRESSION_SYSTEM_TAXID: 7108;                                       
SOURCE  20 EXPRESSION_SYSTEM_CELL_LINE: SF9;                                    
SOURCE  21 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS;                          
SOURCE  22 EXPRESSION_SYSTEM_PLASMID: PFASTBAC;                                 
SOURCE  23 MOL_ID: 3;                                                           
SOURCE  24 ORGANISM_SCIENTIFIC: HOMO SAPIENS;                                   
SOURCE  25 ORGANISM_COMMON: HUMAN;                                              
SOURCE  26 ORGANISM_TAXID: 9606;                                                
SOURCE  27 GENE: SEC61A1, SEC61A;                                               
SOURCE  28 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA;                            
SOURCE  29 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM;                             
SOURCE  30 EXPRESSION_SYSTEM_TAXID: 7108;                                       
SOURCE  31 EXPRESSION_SYSTEM_CELL_LINE: SF9;                                    
SOURCE  32 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS;                          
SOURCE  33 EXPRESSION_SYSTEM_PLASMID: PFASTBAC;                                 
SOURCE  34 MOL_ID: 4;                                                           
SOURCE  35 ORGANISM_SCIENTIFIC: LYNGBYA BOUILLONII;                             
SOURCE  36 ORGANISM_TAXID: 207920                                               
KEYWDS    TRANSLOCON, INHIBITOR, PROTEIN TRANSLOCATION, PROTEIN TRANSPORT,      
KEYWDS   2 PROTEIN TRANSPORT-INHIBITOR COMPLEX                                  
EXPDTA    ELECTRON MICROSCOPY                                                   
AUTHOR    E.PARK,S.ITSKANOV                                                     
REVDAT   4   13-NOV-24 8DNZ    1       REMARK                                   
REVDAT   3   15-NOV-23 8DNZ    1       LINK   ATOM                              
REVDAT   2   06-SEP-23 8DNZ    1       JRNL                                     
REVDAT   1   24-MAY-23 8DNZ    0                                                
JRNL        AUTH   S.ITSKANOV,L.WANG,T.JUNNE,R.SHERRIFF,L.XIAO,N.BLANCHARD,     
JRNL        AUTH 2 W.Q.SHI,C.FORSYTH,D.HOEPFNER,M.SPIESS,E.PARK                 
JRNL        TITL   A COMMON MECHANISM OF SEC61 TRANSLOCON INHIBITION BY SMALL   
JRNL        TITL 2 MOLECULES.                                                   
JRNL        REF    NAT.CHEM.BIOL.                V.  19  1063 2023              
JRNL        REFN                   ESSN 1552-4469                               
JRNL        PMID   37169959                                                     
JRNL        DOI    10.1038/S41589-023-01337-Y                                   
REMARK   2                                                                      
REMARK   2 RESOLUTION.    2.57 ANGSTROMS.                                       
REMARK   3                                                                      
REMARK   3 REFINEMENT.                                                          
REMARK   3   SOFTWARE PACKAGES      : SERIALEM, WARP, CRYOSPARC, COOT,          
REMARK   3                            PHENIX, CRYOSPARC, CRYOSPARC, CRYOSPARC   
REMARK   3   RECONSTRUCTION SCHEMA  : FOURIER SPACE                             
REMARK   3                                                                      
REMARK   3 EM MAP-MODEL FITTING AND REFINEMENT                                  
REMARK   3   PDB ENTRY                    : NULL                                
REMARK   3   REFINEMENT SPACE             : REAL                                
REMARK   3   REFINEMENT PROTOCOL          : FLEXIBLE FIT                        
REMARK   3   REFINEMENT TARGET            : NULL                                
REMARK   3   OVERALL ANISOTROPIC B VALUE  : NULL                                
REMARK   3                                                                      
REMARK   3 FITTING PROCEDURE : NULL                                             
REMARK   3                                                                      
REMARK   3 EM IMAGE RECONSTRUCTION STATISTICS                                   
REMARK   3   NOMINAL PIXEL SIZE (ANGSTROMS)    : NULL                           
REMARK   3   ACTUAL PIXEL SIZE  (ANGSTROMS)    : NULL                           
REMARK   3   EFFECTIVE RESOLUTION (ANGSTROMS)  : 2.570                          
REMARK   3   NUMBER OF PARTICLES               : 497555                         
REMARK   3   CTF CORRECTION METHOD             : PHASE FLIPPING AND AMPLITUDE   
REMARK   3                                       CORRECTION                     
REMARK   3                                                                      
REMARK   3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL                    
REMARK   3                                                                      
REMARK   3 OTHER DETAILS: NULL                                                  
REMARK   4                                                                      
REMARK   4 8DNZ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11                         
REMARK 100                                                                      
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 16-JUL-22.                  
REMARK 100 THE DEPOSITION ID IS D_1000266965.                                   
REMARK 245                                                                      
REMARK 245 EXPERIMENTAL DETAILS                                                 
REMARK 245   RECONSTRUCTION METHOD          : SINGLE PARTICLE                   
REMARK 245   SPECIMEN TYPE                  : NULL                              
REMARK 245                                                                      
REMARK 245 ELECTRON MICROSCOPE SAMPLE                                           
REMARK 245   SAMPLE TYPE                    : PARTICLE                          
REMARK 245   PARTICLE TYPE                  : POINT                             
REMARK 245   NAME OF SAMPLE                 : A HUMAN-YEAST CHIMERIC SEC        
REMARK 245                                    COMPLEX TREATED WITH APRATOXIN F  
REMARK 245   SAMPLE CONCENTRATION (MG ML-1) : 10.00                             
REMARK 245   SAMPLE SUPPORT DETAILS         : NULL                              
REMARK 245   SAMPLE VITRIFICATION DETAILS   : BLOT FOR 4 SECONDS BEFORE         
REMARK 245                                    PLUNGING                          
REMARK 245   SAMPLE BUFFER                  : NULL                              
REMARK 245   PH                             : 7.50                              
REMARK 245   SAMPLE DETAILS                 : NULL                              
REMARK 245                                                                      
REMARK 245 DATA ACQUISITION                                                     
REMARK 245   DATE OF EXPERIMENT                : NULL                           
REMARK 245   NUMBER OF MICROGRAPHS-IMAGES      : NULL                           
REMARK 245   TEMPERATURE (KELVIN)              : NULL                           
REMARK 245   MICROSCOPE MODEL                  : FEI TITAN KRIOS                
REMARK 245   DETECTOR TYPE                     : GATAN K3 (6K X 4K)             
REMARK 245   MINIMUM DEFOCUS (NM)              : 800.00                         
REMARK 245   MAXIMUM DEFOCUS (NM)              : 1600.00                        
REMARK 245   MINIMUM TILT ANGLE (DEGREES)      : NULL                           
REMARK 245   MAXIMUM TILT ANGLE (DEGREES)      : NULL                           
REMARK 245   NOMINAL CS                        : 2.70                           
REMARK 245   IMAGING MODE                      : BRIGHT FIELD                   
REMARK 245   ELECTRON DOSE (ELECTRONS NM**-2)  : 5000.00                        
REMARK 245   ILLUMINATION MODE                 : FLOOD BEAM                     
REMARK 245   NOMINAL MAGNIFICATION             : 81000                          
REMARK 245   CALIBRATED MAGNIFICATION          : NULL                           
REMARK 245   SOURCE                            : FIELD EMISSION GUN             
REMARK 245   ACCELERATION VOLTAGE (KV)         : 300                            
REMARK 245   IMAGING DETAILS                   : NULL                           
REMARK 247                                                                      
REMARK 247 ELECTRON MICROSCOPY                                                  
REMARK 247  THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON          
REMARK 247  MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE              
REMARK 247  THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES           
REMARK 247  ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION         
REMARK 247  OF THE STRUCTURE FACTORS.                                           
REMARK 300                                                                      
REMARK 300 BIOMOLECULE: 1                                                       
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM                
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN                  
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON               
REMARK 300 BURIED SURFACE AREA.                                                 
REMARK 350                                                                      
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN           
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE                
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS          
REMARK 350 GIVEN BELOW.  BOTH NON-CRYSTALLOGRAPHIC AND                          
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.                               
REMARK 350                                                                      
REMARK 350 BIOMOLECULE: 1                                                       
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC                        
REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, C, A, D                            
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 465                                                                      
REMARK 465 MISSING RESIDUES                                                     
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE                       
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN               
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)                
REMARK 465                                                                      
REMARK 465   M RES C SSSEQI                                                     
REMARK 465     MET B     1                                                      
REMARK 465     ASP B     2                                                      
REMARK 465     GLN B     3                                                      
REMARK 465     VAL B     4                                                      
REMARK 465     MET B     5                                                      
REMARK 465     GLY B    67                                                      
REMARK 465     GLY B    68                                                      
REMARK 465     MET C     1                                                      
REMARK 465     PRO C     2                                                      
REMARK 465     GLY C     3                                                      
REMARK 465     PRO C     4                                                      
REMARK 465     THR C     5                                                      
REMARK 465     PRO C     6                                                      
REMARK 465     SER C     7                                                      
REMARK 465     GLY C     8                                                      
REMARK 465     THR C     9                                                      
REMARK 465     ASN C    10                                                      
REMARK 465     VAL C    11                                                      
REMARK 465     GLY C    12                                                      
REMARK 465     SER C    13                                                      
REMARK 465     SER C    14                                                      
REMARK 465     GLY C    15                                                      
REMARK 465     ARG C    16                                                      
REMARK 465     SER C    17                                                      
REMARK 465     PRO C    18                                                      
REMARK 465     SER C    19                                                      
REMARK 465     LYS C    20                                                      
REMARK 465     ALA C    21                                                      
REMARK 465     VAL C    22                                                      
REMARK 465     ALA C    23                                                      
REMARK 465     ALA C    24                                                      
REMARK 465     ARG C    25                                                      
REMARK 465     ALA C    26                                                      
REMARK 465     ALA C    27                                                      
REMARK 465     GLY C    28                                                      
REMARK 465     SER C    29                                                      
REMARK 465     THR C    30                                                      
REMARK 465     VAL C    31                                                      
REMARK 465     ARG C    32                                                      
REMARK 465     GLN C    33                                                      
REMARK 465     ARG C    34                                                      
REMARK 465     LYS C    35                                                      
REMARK 465     ASN C    36                                                      
REMARK 465     ALA C    37                                                      
REMARK 465     SER C    38                                                      
REMARK 465     CYS C    39                                                      
REMARK 465     GLY C    40                                                      
REMARK 465     THR C    41                                                      
REMARK 465     ARG C    42                                                      
REMARK 465     SER C    43                                                      
REMARK 465     ALA C    44                                                      
REMARK 465     GLY C    45                                                      
REMARK 465     ARG C    46                                                      
REMARK 465     THR C    47                                                      
REMARK 465     THR C    48                                                      
REMARK 465     SER C    49                                                      
REMARK 465     ALA C    50                                                      
REMARK 465     GLY C    51                                                      
REMARK 465     THR C    52                                                      
REMARK 465     GLY C    53                                                      
REMARK 465     GLY C    54                                                      
REMARK 465     MET C    55                                                      
REMARK 465     TRP C    56                                                      
REMARK 465     ARG C    57                                                      
REMARK 465     PHE C    58                                                      
REMARK 465     TYR C    59                                                      
REMARK 465     THR C    60                                                      
REMARK 465     GLU C    61                                                      
REMARK 465     ASP C    62                                                      
REMARK 465     SER C    63                                                      
REMARK 465     PRO C    64                                                      
REMARK 465     MET A     1                                                      
REMARK 465     ALA A     2                                                      
REMARK 465     ASP A   326                                                      
REMARK 465     THR A   327                                                      
REMARK 465     SER A   328                                                      
REMARK 465     SER A   329                                                      
REMARK 465     GLY A   330                                                      
REMARK 465     GLY A   331                                                      
REMARK 465     PRO A   332                                                      
REMARK 465     ALA A   333                                                      
REMARK 465     GLY A   469                                                      
REMARK 465     SER A   470                                                      
REMARK 465     MET A   471                                                      
REMARK 465     GLY A   472                                                      
REMARK 465     ALA A   473                                                      
REMARK 465     LEU A   474                                                      
REMARK 465     LEU A   475                                                      
REMARK 465     PHE A   476                                                      
REMARK 470                                                                      
REMARK 470 MISSING ATOM                                                         
REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER;           
REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;          
REMARK 470 I=INSERTION CODE):                                                   
REMARK 470   M RES CSSEQI  ATOMS                                                
REMARK 470     GLN B   6    CG   CD   OE1  NE2                                  
REMARK 470     GLU B   9    CG   CD   OE1  OE2                                  
REMARK 470     ARG B  12    CG   CD   NE   CZ   NH1  NH2                        
REMARK 470     ILE A   3    CG1  CG2  CD1                                       
REMARK 470     PHE A  12    CG   CD1  CD2  CE1  CE2  CZ                         
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT                     
REMARK 500                                                                      
REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT.                            
REMARK 500                                                                      
REMARK 500  ATM1  RES C  SSEQI   ATM2  RES C  SSEQI           DISTANCE          
REMARK 500   OD2  ASP A   139     OG   SER A   141              2.18            
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: TORSION ANGLES                                             
REMARK 500                                                                      
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:            
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;               
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).                             
REMARK 500                                                                      
REMARK 500 STANDARD TABLE:                                                      
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)                    
REMARK 500                                                                      
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-           
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400            
REMARK 500                                                                      
REMARK 500  M RES CSSEQI        PSI       PHI                                   
REMARK 500    SER A  56       52.47    -94.61                                   
REMARK 500    MET A  77       35.83    -98.49                                   
REMARK 500    PHE A 312       58.40    -95.18                                   
REMARK 500    SER A 408       55.91    -93.66                                   
REMARK 500    SER A 443     -174.58     80.27                                   
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 900                                                                      
REMARK 900 RELATED ENTRIES                                                      
REMARK 900 RELATED ID: EMD-27585   RELATED DB: EMDB                             
REMARK 900 CRYO-EM STRUCTURE OF THE HUMAN SEC61 COMPLEX INHIBITED BY APRATOXIN  
REMARK 900 F                                                                    
DBREF  8DNZ B    1    68  UNP    P60059   SC61G_HUMAN      1     68             
DBREF  8DNZ C    1    96  UNP    P60468   SC61B_HUMAN      1     96             
DBREF  8DNZ A    1   476  UNP    P61619   S61A1_HUMAN      1    476             
DBREF  8DNZ D    1     5  PDB    8DNZ     8DNZ             1      5             
SEQADV 8DNZ TYR A  263  UNP  P61619    VAL   263 CONFLICT                       
SEQADV 8DNZ GLU A  264  UNP  P61619    ASP   264 ENGINEERED MUTATION            
SEQADV 8DNZ ARG A  268  UNP  P61619    LYS   268 ENGINEERED MUTATION            
SEQADV 8DNZ THR A  270  UNP  P61619    ALA   270 ENGINEERED MUTATION            
SEQADV 8DNZ LYS A  271  UNP  P61619    ARG   271 ENGINEERED MUTATION            
SEQADV 8DNZ VAL A  272  UNP  P61619    TYR   272 ENGINEERED MUTATION            
SEQADV 8DNZ ILE A  276  UNP  P61619    TYR   276 ENGINEERED MUTATION            
SEQADV 8DNZ GLY A  277  UNP  P61619    ASN   277 ENGINEERED MUTATION            
SEQADV 8DNZ ILE A  278  UNP  P61619    THR   278 ENGINEERED MUTATION            
SEQADV 8DNZ PRO A  387  UNP  P61619    ALA   387 CONFLICT                       
SEQADV 8DNZ ARG A  388  UNP  P61619    LYS   388 CONFLICT                       
SEQADV 8DNZ ILE A  390  UNP  P61619    VAL   390 CONFLICT                       
SEQADV 8DNZ PHE A  394  UNP  P61619    LEU   394 ENGINEERED MUTATION            
SEQADV 8DNZ ASP A  396  UNP  P61619    GLU   396 CONFLICT                       
SEQADV 8DNZ GLY A  398  UNP  P61619    GLN   398 CONFLICT                       
SEQADV 8DNZ ILE A  401  UNP  P61619    MET   401 ENGINEERED MUTATION            
SEQADV 8DNZ ASN A  402  UNP  P61619    ARG   402 ENGINEERED MUTATION            
SEQADV 8DNZ LYS A  404  UNP  P61619    HIS   404 ENGINEERED MUTATION            
SEQADV 8DNZ ILE A  409  UNP  P61619    MET   409 ENGINEERED MUTATION            
SEQADV 8DNZ TYR A  410  UNP  P61619    VAL   410 ENGINEERED MUTATION            
SEQADV 8DNZ ARG A  411  UNP  P61619    HIS   411 ENGINEERED MUTATION            
SEQADV 8DNZ LYS A  414  UNP  P61619    ASN   414 CONFLICT                       
SEQADV 8DNZ LYS A  415  UNP  P61619    ARG   415 CONFLICT                       
SEQADV 8DNZ ILE A  416  UNP  P61619    TYR   416 CONFLICT                       
SEQRES   1 B   68  MET ASP GLN VAL MET GLN PHE VAL GLU PRO SER ARG GLN          
SEQRES   2 B   68  PHE VAL LYS ASP SER ILE ARG LEU VAL LYS ARG CYS THR          
SEQRES   3 B   68  LYS PRO ASP ARG LYS GLU PHE GLN LYS ILE ALA MET ALA          
SEQRES   4 B   68  THR ALA ILE GLY PHE ALA ILE MET GLY PHE ILE GLY PHE          
SEQRES   5 B   68  PHE VAL LYS LEU ILE HIS ILE PRO ILE ASN ASN ILE ILE          
SEQRES   6 B   68  VAL GLY GLY                                                  
SEQRES   1 C   96  MET PRO GLY PRO THR PRO SER GLY THR ASN VAL GLY SER          
SEQRES   2 C   96  SER GLY ARG SER PRO SER LYS ALA VAL ALA ALA ARG ALA          
SEQRES   3 C   96  ALA GLY SER THR VAL ARG GLN ARG LYS ASN ALA SER CYS          
SEQRES   4 C   96  GLY THR ARG SER ALA GLY ARG THR THR SER ALA GLY THR          
SEQRES   5 C   96  GLY GLY MET TRP ARG PHE TYR THR GLU ASP SER PRO GLY          
SEQRES   6 C   96  LEU LYS VAL GLY PRO VAL PRO VAL LEU VAL MET SER LEU          
SEQRES   7 C   96  LEU PHE ILE ALA SER VAL PHE MET LEU HIS ILE TRP GLY          
SEQRES   8 C   96  LYS TYR THR ARG SER                                          
SEQRES   1 A  476  MET ALA ILE LYS PHE LEU GLU VAL ILE LYS PRO PHE CYS          
SEQRES   2 A  476  VAL ILE LEU PRO GLU ILE GLN LYS PRO GLU ARG LYS ILE          
SEQRES   3 A  476  GLN PHE LYS GLU LYS VAL LEU TRP THR ALA ILE THR LEU          
SEQRES   4 A  476  PHE ILE PHE LEU VAL CYS CYS GLN ILE PRO LEU PHE GLY          
SEQRES   5 A  476  ILE MET SER SER ASP SER ALA ASP PRO PHE TYR TRP MET          
SEQRES   6 A  476  ARG VAL ILE LEU ALA SER ASN ARG GLY THR LEU MET GLU          
SEQRES   7 A  476  LEU GLY ILE SER PRO ILE VAL THR SER GLY LEU ILE MET          
SEQRES   8 A  476  GLN LEU LEU ALA GLY ALA LYS ILE ILE GLU VAL GLY ASP          
SEQRES   9 A  476  THR PRO LYS ASP ARG ALA LEU PHE ASN GLY ALA GLN LYS          
SEQRES  10 A  476  LEU PHE GLY MET ILE ILE THR ILE GLY GLN SER ILE VAL          
SEQRES  11 A  476  TYR VAL MET THR GLY MET TYR GLY ASP PRO SER GLU MET          
SEQRES  12 A  476  GLY ALA GLY ILE CYS LEU LEU ILE THR ILE GLN LEU PHE          
SEQRES  13 A  476  VAL ALA GLY LEU ILE VAL LEU LEU LEU ASP GLU LEU LEU          
SEQRES  14 A  476  GLN LYS GLY TYR GLY LEU GLY SER GLY ILE SER LEU PHE          
SEQRES  15 A  476  ILE ALA THR ASN ILE CYS GLU THR ILE VAL TRP LYS ALA          
SEQRES  16 A  476  PHE SER PRO THR THR VAL ASN THR GLY ARG GLY MET GLU          
SEQRES  17 A  476  PHE GLU GLY ALA ILE ILE ALA LEU PHE HIS LEU LEU ALA          
SEQRES  18 A  476  THR ARG THR ASP LYS VAL ARG ALA LEU ARG GLU ALA PHE          
SEQRES  19 A  476  TYR ARG GLN ASN LEU PRO ASN LEU MET ASN LEU ILE ALA          
SEQRES  20 A  476  THR ILE PHE VAL PHE ALA VAL VAL ILE TYR PHE GLN GLY          
SEQRES  21 A  476  PHE ARG TYR GLU LEU PRO ILE ARG SER THR LYS VAL ARG          
SEQRES  22 A  476  GLY GLN ILE GLY ILE TYR PRO ILE LYS LEU PHE TYR THR          
SEQRES  23 A  476  SER ASN ILE PRO ILE ILE LEU GLN SER ALA LEU VAL SER          
SEQRES  24 A  476  ASN LEU TYR VAL ILE SER GLN MET LEU SER ALA ARG PHE          
SEQRES  25 A  476  SER GLY ASN LEU LEU VAL SER LEU LEU GLY THR TRP SER          
SEQRES  26 A  476  ASP THR SER SER GLY GLY PRO ALA ARG ALA TYR PRO VAL          
SEQRES  27 A  476  GLY GLY LEU CYS TYR TYR LEU SER PRO PRO GLU SER PHE          
SEQRES  28 A  476  GLY SER VAL LEU GLU ASP PRO VAL HIS ALA VAL VAL TYR          
SEQRES  29 A  476  ILE VAL PHE MET LEU GLY SER CYS ALA PHE PHE SER LYS          
SEQRES  30 A  476  THR TRP ILE GLU VAL SER GLY SER SER PRO ARG ASP ILE          
SEQRES  31 A  476  ALA LYS GLN PHE LYS ASP GLN GLY MET VAL ILE ASN GLY          
SEQRES  32 A  476  LYS ARG GLU THR SER ILE TYR ARG GLU LEU LYS LYS ILE          
SEQRES  33 A  476  ILE PRO THR ALA ALA ALA PHE GLY GLY LEU CYS ILE GLY          
SEQRES  34 A  476  ALA LEU SER VAL LEU ALA ASP PHE LEU GLY ALA ILE GLY          
SEQRES  35 A  476  SER GLY THR GLY ILE LEU LEU ALA VAL THR ILE ILE TYR          
SEQRES  36 A  476  GLN TYR PHE GLU ILE PHE VAL LYS GLU GLN SER GLU VAL          
SEQRES  37 A  476  GLY SER MET GLY ALA LEU LEU PHE                              
SEQRES   1 D    5  T69 0A1 MAA IML MAA                                          
HET    T69  D   1      55                                                       
HET    0A1  D   2      24                                                       
HET    MAA  D   3      13                                                       
HET    IML  D   4      22                                                       
HET    MAA  D   5      13                                                       
HETNAM     T69 (2E)-3-{(2R,4S)-2-[(2S,3S,5S,7S)-3,7-DIHYDROXY-5,8,8-            
HETNAM   2 T69  TRIMETHYLNONAN-2-YL]-1,3-THIAZOLIDIN-4-YL}-2-                   
HETNAM   3 T69  METHYLPROP-2-ENOIC ACID                                         
HETNAM     0A1 O-METHYL-L-TYROSINE                                              
HETNAM     MAA N-METHYL-L-ALANINE                                               
HETNAM     IML N-METHYL-ISOLEUCINE                                              
FORMUL   4  T69    C19 H35 N O4 S                                               
FORMUL   4  0A1    C10 H13 N O3                                                 
FORMUL   4  MAA    2(C4 H9 N O2)                                                
FORMUL   4  IML    C7 H15 N O2                                                  
HELIX    1 AA1 PHE B    7  CYS B   25  1                                  19    
HELIX    2 AA2 ASP B   29  VAL B   66  1                                  38    
HELIX    3 AA3 GLY C   69  SER C   96  1                                  28    
HELIX    4 AA4 LYS A    4  ILE A    9  1                                   6    
HELIX    5 AA5 ILE A    9  VAL A   14  1                                   6    
HELIX    6 AA6 GLN A   27  CYS A   46  1                                  20    
HELIX    7 AA7 PHE A   62  ARG A   66  5                                   5    
HELIX    8 AA8 ILE A   81  ALA A   97  1                                  17    
HELIX    9 AA9 THR A  105  THR A  134  1                                  30    
HELIX   10 AB1 ASP A  139  GLY A  144  1                                   6    
HELIX   11 AB2 GLY A  144  LYS A  171  1                                  28    
HELIX   12 AB3 SER A  177  SER A  197  1                                  21    
HELIX   13 AB4 GLY A  211  ARG A  223  1                                  13    
HELIX   14 AB5 LYS A  226  TYR A  235  1                                  10    
HELIX   15 AB6 ASN A  241  GLY A  260  1                                  20    
HELIX   16 AB7 ASN A  288  PHE A  312  1                                  25    
HELIX   17 AB8 ASN A  315  GLY A  322  1                                   8    
HELIX   18 AB9 GLY A  340  LEU A  345  1                                   6    
HELIX   19 AC1 SER A  350  ASP A  357  1                                   8    
HELIX   20 AC2 ASP A  357  GLU A  381  1                                  25    
HELIX   21 AC3 SER A  386  GLY A  398  1                                  13    
HELIX   22 AC4 ILE A  409  LEU A  438  1                                  30    
HELIX   23 AC5 GLY A  442  VAL A  468  1                                  27    
SHEET    1 AA1 2 LYS C  67  VAL C  68  0                                        
SHEET    2 AA1 2 GLU A  18  ILE A  19  1  O  GLU A  18   N  VAL C  68           
SHEET    1 AA2 2 THR A 200  ASN A 202  0                                        
SHEET    2 AA2 2 MET A 207  PHE A 209 -1  O  GLU A 208   N  VAL A 201           
SHEET    1 AA3 3 ILE A 276  LYS A 282  0                                        
SHEET    2 AA3 3 ARG A 262  SER A 269 -1  N  TYR A 263   O  ILE A 281           
SHEET    3 AA3 3 MET A 399  ILE A 401 -1  O  VAL A 400   N  ARG A 268           
SHEET    1 AA4 2 THR A 323  SER A 325  0                                        
SHEET    2 AA4 2 TYR A 336  GLY A 339 -1  O  VAL A 338   N  THR A 323           
LINK         C48 T69 D   1                 N   0A1 D   2     1555   1555  1.41  
LINK         O02 T69 D   1                 C   MAA D   5     1555   1555  1.37  
LINK         C   0A1 D   2                 N   MAA D   3     1555   1555  1.42  
LINK         C   MAA D   3                 N   IML D   4     1555   1555  1.43  
LINK         C   IML D   4                 N   MAA D   5     1555   1555  1.42  
CRYST1    1.000    1.000    1.000  90.00  90.00  90.00 P 1                      
ORIGX1      1.000000  0.000000  0.000000        0.00000                         
ORIGX2      0.000000  1.000000  0.000000        0.00000                         
ORIGX3      0.000000  0.000000  1.000000        0.00000                         
SCALE1      1.000000  0.000000  0.000000        0.00000                         
SCALE2      0.000000  1.000000  0.000000        0.00000                         
SCALE3      0.000000  0.000000  1.000000        0.00000